CLINICAL_TRIALS
research
· 2024-08-20
Clinical Trial Update: Effects of Adrenal Artery Ablation and Spironolactone in Patients With Primary Aldosteronism [NA]
Summary
A clinical trial is evaluating adrenal artery ablation in combination with spironolactone for patients with primary aldosteronism; recruitment is ongoing. The s…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Third Military Medical University | Conditions: Primary Aldosteronism, Hypertension | NA | Status: RECRUITING